在情绪障碍中使用亲肠道特拉佐的临床经验:文献综述
Calogero Crapanzano1, Ilaria Casolaro2, Anna Julia Krupa3
1Azienda Sanitaria Provinciale di Agrigento, CSM Licata, Licata, Italy.
Psychiatria polska
|September 1, 2024
概括
亲肠道特拉佐在严重抑郁症 (MDD) 中显示出有效性和耐受性. 它也可能对双相情感障碍的激动有帮助,尽管需要对混因素进行更多研究.
科学领域:
- 药理学 药理学是指药理学的学科.
- 精神病学是一个精神病学.
- 临床医学 临床医学
背景情况:
- 特拉佐是一种血清激素抗剂/再吸收抑制剂,已被批准用于主要抑郁症 (MDD).
- 与口服形式相比,对亲肠道 (注射) 特拉佐配方的证据有限.
- 本综述重点介绍的是亲肠道特拉佐在情绪障碍中的作用.
研究的目的:
- 审查亲肠道特拉佐的药理性质和临床数据.
- 为了评估亲肠道特拉佐在情绪障碍中的疗效和安全性.
- 评估其在特定患者群体中的潜在作用.
主要方法:
- 一个叙事文学的评论.
- 在PubMed和Web of Science数据库中进行的搜索.
- 包括评估亲肠道特拉佐在情绪障碍中的研究.
主要成果:
- 四项研究表明,腹腔内注射的特拉佐对重度抑郁症有效且耐受性良好.
- 三项研究报告了在双相情感障碍中非标签性使用激动性,有潜在的混因素.
- 亲肠道特拉佐似乎适用于患有治疗引起的躁狂 (TEM) 高风险的患者.
结论:
- 有限的证据支持通过肠道注射的特拉佐治疗严重抑郁症.
- 亲肠道特拉佐是治疗特定精神疾病的潜在选择.
- 进一步的研究可能会澄清它在管理激动和预防TEM方面的作用.
相关概念视频
Antidepressant Drugs: MAOIs and Other Agents
205
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
205
Sedatives and Hypnotics Drugs: Miscellaneous Agents
159
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
159
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
335
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
335
Management of Insomnia
235
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
235
Drug Therapy
40
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
40
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
104
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
104


